Search Results - "Kuban, D. A."

Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer by Bian, S.X., Kuban, D.A., Levy, L.B., Oh, J., Castle, K.O., Pugh, T.J., Choi, S., McGuire, S.E., Nguyen, Q.N., Frank, S.J., Nguyen, P.L., Lee, A.K., Hoffman, K.E.

“…Dose-escalated (DE) radiation therapy (RT) and androgen deprivation therapy (ADT) improve prostate cancer outcomes over standard-dose RT. The benefit of adding…”
Get full text

Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-institutional Pooled Analysis by Shipley, William U, Thames, Howard D, Sandler, Howard M, Hanks, Gerald E, Zietman, Anthony L, Perez, Carlos A, Kuban, Deborah A, Hancock, Steven L, Smith, Cyndi D

“…CONTEXT Prostate-specific antigen (PSA) evaluation leads to the early detection of both prostate cancer and recurrences following primary treatment…”
Get full text

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer by Taylor, N, Kelly, J F, Kuban, D A, Babaian, R J, Pisters, L L, Pollack, A

“…The optimal role of radiotherapy (RT) to the prostate bed after radical prostatectomy (RP) is the subject of much debate. In this study, the results of…”
Get more information

Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy by Holliday, E B, Kuban, D A, Levy, L B, Bolukbasi, Y, Master, P, Choi, S, Nguyen, Q, McGuire, S E, Mahmood, U, Frank, S J, Hoffman, K E

“…Background: Which men benefit most from adding androgen deprivation therapy (ADT) to salvage radiation therapy (SRT) after prostatectomy has not clearly been…”
Get full text

Dual radiobiological interpretations of retrospective clinical data: the time factor by Thames, H. D., D'souza, W., Kuban, D. A.

“…Dual interpretations are different radiobiological mechanisms that explain theoretically the same observed results. Radiobiological interpretations of the time…”
Get full text

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer by Kuban, D A, el-Mahdi, A M, Schellhammer, P F

“…This study was undertaken to assess the predictive value of pretreatment prostate-specific antigen (PSA) and the difference between clinical and PSA…”
Get more information

Treatment of clinical local failure after radiation therapy for prostate carcinoma by Schellhammer, P F, Kuban, D A, el-Mahdi, A M

“…From a base population of 634 patients with prostate cancer treated by external beam therapy with a median followup of 8 years and 123 patients treated by…”
Get more information

Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy by Incognito, L S, Cazares, L H, Schellhammer, P F, Kuban, D A, Van Dyk, E O, Moriarty, R P, Wright, Jr, G L, Somers, K D

“…p53 gene mutations are among the most common specific genetic alterations in human cancer. Inactivation of p53 and subsequent protein accumulation has been…”
Get more information

Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy by Kim, J A, Kuban, D A, el-Mahdi, A M, Schellhammer, P F

“…To characterize the racial differences in prognostic factors and treatment outcome for patients undergoing radiation therapy for carcinoma of the prostate…”
Get more information

Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients by Cerne, J Z, McGuire, S E, Grant, S R, Munsell, M F, Lee, A K, Kudchadker, R J, Choi, S L, Mahmood, U, Hoffman, K E, Pugh, T J, Frank, S J, Kuban, D A

“…Background: In prostate cancer patients treated with androgen deprivation therapy (ADT) and radiation therapy (RT), a pre-RT PSA level ⩾0.5 ng ml −1 ,…”
Get full text

Quality of life after treatment for localized prostate cancer: differences based on treatment modality by Davis, J W, Kuban, D A, Lynch, D F, Schellhammer, P F

“…Brachytherapy with 103palladium (103Pd) is an increasingly administered treatment modality for localized prostate cancer. We compared general and disease…”
Get more information

Potential benefit of improved local tumor control in patients with prostate carcinoma by Kuban, D A, el-Mahdi, A M, Schellhammer, P F

“…In the case of prostate carcinoma, radiation therapy is a locally applied treatment modality in a malignancy known for systemic dissemination. Because…”
Get more information

Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate by Kuban, D A, Delbridge, T, el-Mahdi, A M, Schellhammer, P F

“…A total of 31 patients with prostatic adenocarcinoma received a total of 35 half-body irradiation treatments; 13 treatments of 600 to 800 cGy. to the upper…”
Get more information

Prostate-specific antigen after radiation therapy. Prognosis by pretreatment level and post-treatment nadir by Schellhammer, P F, el-Mahdi, A M, Kuban, D A, Wright, Jr, G L

“…After external beam radiation therapy, pretreatment prostate-specific antigen (PSA) is the most powerful predictor of outcome as measured PSA (biochemical)…”
Get more information

Characteristics of spinal cord compression in adenocarcinoma of prostate by Kuban, D A, el-Mahdi, A M, Sigfred, S V, Schellhammer, P F, Babb, T J

“…Of 611 patients with biopsy-proved adenocarcinoma of the prostate, spinal cord compression developed in 41 (6.7%) at a median interval of twenty-four months…”
Get more information

Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma by Kuban, D A, el-Mahdi, A M, Schellhammer, P F

“…Of 495 patients definitively irradiated for prostatic carcinoma, 286 with a minimum follow-up of thirty-six months were studied. While tumor histology appeared…”
Get more information

Brain metastases from transitional cell carcinoma of urinary bladder by Anderson, R S, el-Mahdi, A M, Kuban, D A, Higgins, E M

“…Of 293 patients with transitional cell carcinoma of the bladder seen at our institution between April 1977 and December 1987, 9 patients were found to have…”
Get more information

Morbidity and mortality of local failure after definitive therapy for prostate cancer by Schellhammer, P F, Whitmore, 3rd, R B, Kuban, D A, el-Mahdi, A M, Ladaga, L A

“…We reviewed our experience with morbidity and mortality associated with clinical local failure after definitive therapy for adenocarcinoma of the prostate by…”
Get more information

High dose rate vaginal brachytherapy in early stage endometrial carcinoma : Preliminary analysis by HONG, J. J, YACOUB, S. F, BLEVINS, J. C, KUBAN, D. A, EL-MAHDI, A. M

“…From 1987 to 1993, 69 women diagnosed with FIGO stages I and II carcinoma of the endometrium underwent postoperative adjuvant irradiation (RT) under protocol…”
Get full text

Local failure after definitive radiation or surgical therapy for carcinoma of the prostate and options for prevention and therapy by Schellhammer, P F, Kuban, D A, el-Mahdi, A M

“…The incidence of local failure and its relation to distant failure following definitive therapy of carcinoma of the prostate is discussed. Local failure may…”
Get more information